The globalmicroRNA market根据Polaris市场研究的一项新的研究，预计尺寸将达到2028美元的351亿美元。yabo官网入口那个报告“MicroRNA市场份额，规模，趋势，行业分析报告，产品（仪器，耗材）;通过服务（服务类型，标本）;通过申请（癌症，传染病，免疫疾病，心血管疾病，神经疾病）;通过最终使用;按地区;分部预测，2021 - 2028”gives a detailed insight into current market dynamics and provides analysis on future market growth.
MicroRNA作为生物标志物的上升采用也在推动市场。这些生物标志物在全基因组人口研究中尤为重要，数据驱动方法，因为与传统程序相比，它们具有证明高稳健性和重现性的能力。因此，这种分子用作开发生物标志物的有希望的药物候选者。此外，对液体活检的兴趣进一步导致其在生物标志物发现和进一步发展方面的重要性。
Continuous rise in research activities has also explored the potential of microRNA biomarkers across prognosis, therapeutics, and diagnosis to favor the market expansion in near future. In this direction, in January 2020, research scholars have explored the presence of microRNA in the peripheral blood vessel as a biomarker to diagnose bipolar II disorder using NGS. These microRNAs could serve as a possible non-invasive solution to diagnose any indication of neurodegenerative disorders.
The cardiovascular segment is projected to witness a lucrative market growth rate over the assessment period. This is primarily due to the introduction of novel biomarkers for early diagnosis of heart-related ailments, and significant investments in the sector.
microRNAs are presumed to be an attractive option for cardiovascular therapeutics due to their several benefits such as tissue-specific expressions, secretion of body fluids, and stability. Moreover, many studies gave also pointed to the role of microRNAs in the regulation of lipoprotein metabolism, hypertension, blood pressure, and even progression of adjacent co-morbidities.
有问题吗？在通过单击下面的链接，请在购买此报告之前请求示例或进行查询：//m.nkkjrh.com/idustry-analysis/microrna-market/request-for- sample.
亚太市场预计将在MicroRNA研究期间见证有利可图的增长率。该区域的增长主要是由于基因组研究中基因组学和蛋白质组学的进步以及支持研究目标的新工具的快速采用。
For instance, in March 2021, researchers based in Chinese universities have identified blood microRNA as a potential biomarker for hepatic sinusoidal obstruction syndrome via microarray-based profiling. In addition, a market study has also paved several computational tools to predict the relation between miRNA and its target microRNA.
在MicroRNA行业中运营的市场参与者包括Merck Kgaa，Thermo Fisher，Biogenex，新英格兰Biolabs，Horizo n Discovery，Genecopoeia，Quantabio，Nanostring，Seqmatic LLC，Sistex Scotland Limited，Synlogic，Qiagen，Miltenyi Biotec，Biodynamics Laboratory Inc.，Origene Technologies。
Polaris Market research has segmented the microRNAs market report on the basis of product, services, application, end-use and region:
MicroRNA，产品展望（收入 - 百万，2016 - 2028）
- Instruments
- 消耗品
MicroRNA，服务前景（收入 - 百万，2016 - 2028）
- Service Type
- 隔离和纯化
- miRNA cDNA合成
- 分析，本地化和量化
- Functional Analysis
- 其他
- 标本
- 全血
- 血清
- 等离子体
- FFPE.
- 新鲜的冷冻组织
- 其他
microRNA, Application Outlook (Revenue – USD Million, 2016 – 2028)
- Cancer
- Infectious Diseases
- Immunological Disorder
- 心血管疾病
- Neurological Disease
- 其他
MicroRNA，最终使用前景（收入 - 百万，2016 - 2028）
- Biotechnology & Pharmaceutical Companies
- 学术和政府研究机构
- 其他
microRNA, by Regional Outlook (Revenue – USD Million, 2016 – 2028)
- 北美
- 我们。
- Canada
- Europe
- France
- Germany
- 英国
- Italy
- Spain
- 荷兰
- 奥地利
- 亚太地区
- 中国
- India
- 日本
- Malaysia
- 韩国
- 印度尼西亚
- Latin America
- Mexico
- Brazil
- 阿根廷
- 中东和非洲
- 阿联酋
- 沙特阿拉伯
- Israel
- 南非